SIGA Technologies
SIGA
#7361
Rank
HK$3.45 B
Marketcap
HK$48.25
Share price
-2.21%
Change (1 day)
2.65%
Change (1 year)

Revenue for SIGA Technologies (SIGA)

Revenue in 2025 (TTM): HK$1.34 Billion

According to SIGA Technologies's latest financial reports the company's current revenue (TTM ) is HK$1.34 Billion. In 2024 the company made a revenue of HK$1.07 Billion a decrease over the revenue in the year 2023 that were of HK$1.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SIGA Technologies from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$1.34 B24.84%
2024 HK$1.07 B-1.45%
2023 HK$1.09 B26.26%
2022 HK$0.86 B-16.96%
2021 HK$1.04 B7.6%
2020 HK$0.96 B365.12%
2019 HK$0.20 B-94.42%
2018 HK$3.73 B3797.23%
2017 HK$95.85 M-17.52%
2016 HK$0.11 B83.41%
2015 HK$63.36 M160.2%
2014 HK$24.35 M-43.1%
2013 HK$42.79 M-38.45%
2012 HK$69.53 M-29.65%
2011 HK$98.83 M-33.9%
2010 HK$0.14 B39.64%
2009 HK$0.10 B71.82%
2008 HK$62.32 M19.33%
2007 HK$52.22 M-7.47%
2006 HK$56.44 M-14.12%
2005 HK$65.72 M359.84%
2004 HK$14.29 M151.99%
2003 HK$5.67 M
2001 HK$9.04 M139.95%
2000 HK$3.76 M14.12%
1999 HK$3.3 M-14.77%
1998 HK$3.87 M-44.46%
1997 HK$6.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Emergent BioSolutions
EBS
HK$5.84 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$20.23 M-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$7.97 B 494.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$4.66 B 248.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$18.78 B 1,301.29%๐Ÿ‡บ๐Ÿ‡ธ USA